MBX — MBX Biosciences Share News
0.000.00%
Last trade - 00:00MBX Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: MBX Biosciences Announces Executive Leadership Transition To Support The Company’S Next Phase Of Growth
MBX Biosciences falls after executive shakeup
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
MBX Biosciences falls as hormone disorder drug data fall short of expectations
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
MBX Biosciences reports one-year data for hormone disorder drug, shares fall
Brief: Mbx Biosciences Announces One-Year Data Demonstrating Sustained Benefit Of Once-Weekly Canvuparatide As A Potential Pth Replacement Therapy In Chronic Hypoparathyroidism
U.S. STOCKS ON THE MOVE-Barrick Mining, Lumentum, Tesla
MBX rises on obesity drug data showing monthly dosing potential
Brief: Mbx Biosciences Says Phase 3 Trial Of Canvuparatide To Start In Q3 2026
Brief: Mbx Biosciences To Offer Up To $400 Million In Securities - SEC Filing
U.S. RESEARCH ROUNDUP-Carmax, Mirion Technologies, Valmont Industries
US. STOCKS ON THE MOVE-Vertex, IBM, Silver Miners
US. STOCKS ON THE MOVE-Vertex, IBM, silver miners
U.S. STOCKS ON THE MOVE- Birkenstock, CME Group, Citigroup
U.S. STOCKS ON THE MOVE- Birkenstock, CME Group, Citigroup
MBX Biosciences slips after $200 mln stock offering